Could Pay-for-Performance Worsen Health Disparities?
Pay-for-performance (P4P) has become a prominent component of health care funding in the Affordable Care Act (ACA) era. Although the ACA’s future remains unclear, these programs receive bipartisan support and will likely continue to be a part of payment policies. At the same time, racial and class disparities remain among the most pressing of the many challenges facing the US health system. We review evidence of the effects of P4P on disparities at the population and individual levels. Providers caring for predominantly minority patients or those with lower socioeconomic status are known to have poorer quality metrics. Financial penalties run the risk of exacerbating disparities along race and class lines and across hospitals. The evidence regarding P4P programs is mixed, with safety-net hospitals facing greater penalties but with some improvement in outcomes among minority patients. A better understanding of the longitudinal effects of these plans is needed, and policymakers should be conscious of the risks in expanding these programs.
KEY WORDSdisparities pay-for-performance health policy
Compliance with Ethical Standards
Conflict of Interest
Jason H. Wasfy is the recipient of a KL2 TR001100 Career Development Award funded in the area of health disparities research. All other authors declare that they have no conflict of interest.
- 2.Smedley BD, Stith AY, Nelson AR, the Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care, Institute of Medicine. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Washington, D.C.: National Academies Press; 2003.Google Scholar
- 15.Department of Health and Human Services, Office of the Assistant Secretary of Planning and Evaluation. Report to Congress: social risk factors and performance under Medicare’s value-based payment programs. https://aspe.hhs.gov/pdf-report/report-congress-social-risk-factors-and-performance-under-medicares-value-based-purchasing-programs. Accessed: July 10, 2017.